Original Research

Published on 21 Jun 2024

Predictive value of synaptic plasticity for functional decline in patients with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Carolin Balloff
Lisa Kathleen Janßen
Christian Johannes Hartmann
Sven Günther Meuth
Alfons Schnitzler
Iris-Katharina Penner
Philipp Albrecht

Frontiers in Neurology

doi 10.3389/fneur.2024.1410673

949 views

Systematic Review

Published on 18 Jun 2024

Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series

in Multiple Sclerosis and Neuroimmunology

Cristina Scavone
Valerio Liguori
Olusola Jephthah Adungba
Daniele Di Giulio Cesare
Maria Giuseppa Sullo
Vincenzo Andreone
Liberata Sportiello
Giorgia Teresa Maniscalco
Annalisa Capuano

Frontiers in Neurology

doi 10.3389/fneur.2024.1386527

1,336 views

Original Research

Published on 12 Jun 2024

Abnormal brain spontaneous neural activity in neuromyelitis optica spectrum disorder with neuropathic pain

in Multiple Sclerosis and Neuroimmunology

Gendi Wang
Xiang Chen
Xiaoyuan Wang
Yinghui Duan
Hanqing Gao
Xiaopei Ji
Yunfei Zhu
Xuanyi Xiang
Hairong Ma
Yonggang Li

Frontiers in Neurology

doi 10.3389/fneur.2024.1408759

871 views

Perspective

Published on 10 Jun 2024

Sex differences in Huntington's disease from a neuroinflammation perspective

in Multiple Sclerosis and Neuroimmunology

Grace Risby-Jones
John D. Lee
Trent M. Woodruff
Jenny N. Fung

Frontiers in Neurology

doi 10.3389/fneur.2024.1384480

2,376 views

Original Research

Published on 05 Jun 2024

Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation

in Multiple Sclerosis and Neuroimmunology

Leonardo Marchi
Alice Mariottini
Vittorio Viti
Andrea Bianchi
Chiara Nozzoli
Anna Maria Repice
Riccardo Boncompagni
Andrea Ginestroni
Valentina Damato
Alessandro Barilaro

Frontiers in Neurology

doi 10.3389/fneur.2024.1373385

1,179 views
1 citation

Case Report

Published on 05 Jun 2024

A case report of AQP4-IgG-seropositive refractory neuromyelitis optica spectrum disorder patient with Sjögren’s syndrome and pancytopenia treated with inebilizumab

in Multiple Sclerosis and Neuroimmunology

Shasha Li
Yuting Gao
Yang He
Zhaoxu Zhang

Frontiers in Neurology

doi 10.3389/fneur.2024.1371515

1,236 views

Original Research

Published on 23 May 2024

Effect of methylphenidate on oculomotor function in individuals with multiple sclerosis: a pilot randomized placebo-controlled trial

in Multiple Sclerosis and Neuroimmunology

Timothy J. Rich
Aubree Alexander
Ekaterina Dobryakova
Nancy D. Chiaravalloti
John DeLuca
Silvana L Costa

Frontiers in Neurology

doi 10.3389/fneur.2024.1393877

1,114 views

Editorial

Published on 17 May 2024

Editorial: Multiple sclerosis and related disorders: challenges and approaches to mechanisms, biomarkers, and therapeutic targets

in Multiple Sclerosis and Neuroimmunology

Yang Zhou
Philippe Patrick Monnier
Jin-Zhou Feng
Shou-Gang Guo
Cong-Cong Wang

Frontiers in Neurology

doi 10.3389/fneur.2024.1427299

896 views

Mini Review

Published on 16 May 2024

Soluble biomarkers for Neuromyelitis Optica Spectrum Disorders: a mini review

in Multiple Sclerosis and Neuroimmunology

Rachel E. Rodin
Tanuja Chitnis

Frontiers in Neurology

doi 10.3389/fneur.2024.1415535

2,371 views
3 citations

Review

Published on 09 May 2024

Stem cell therapies: a new era in the treatment of multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Lei Wu
Jing Lu
Tianye Lan
Dongmei Zhang
Hanying Xu
Zezheng Kang
Fang Peng
Jian Wang

Frontiers in Neurology

doi 10.3389/fneur.2024.1389697

4,396 views
2 citations

Original Research

Published on 01 May 2024

“A second birthday”? Experiences of persons with multiple sclerosis treated with autologous hematopoietic stem cell transplantation—a qualitative interview study

in Multiple Sclerosis and Neuroimmunology

Timo Volz
Anna Sippel
Felix Fischbach
Johanna Richter
Alice Grizzel Willison
Vivien Häußler
Christoph Heesen

Frontiers in Neurology

doi 10.3389/fneur.2024.1384551

1,374 views

Brief Research Report

Published on 01 May 2024

IL-6 receptor antibody treatment improves muscle weakness in experimental autoimmune myasthenia gravis mouse model

in Multiple Sclerosis and Neuroimmunology

Shota Miyake
Kenichi Serizawa
Shinichi Onishi
Yoshichika Katsura
Masayuki Baba
Mitsue Kurasawa
Haruna Tomizawa-Shinohara
Keigo Yorozu
Yoshihiro Matsumoto
Mariko Noguchi-Sasaki

Frontiers in Neurology

doi 10.3389/fneur.2024.1356300

1,605 views

Original Research

Published on 26 Apr 2024

Patterns of multiple sclerosis presentation to the emergency department

in Multiple Sclerosis and Neuroimmunology

Seraj Makkawi
Alaa Maglan
Osama Khojah
Faris Allaf
Saeed Alamoudi
Mohamed Eldigire Ahmed
Rawaf Alsharif
Meral Altayeb
Abdulrhman Alharthi
Ahmad Abulaban

Frontiers in Neurology

doi 10.3389/fneur.2024.1395822

1,262 views

Case Report

Published on 23 Apr 2024

Case report: Cerebrospinal fluid neutrophilic pleocytosis upon intrathecal triamcinolone injection

in Multiple Sclerosis and Neuroimmunology

Thanos Tsaktanis
Jenny Stritzelberger
Vi Tuong Daniel To
Martin Uhl
Stefan Schwab
Dieter Heuss
Veit Rothhammer

Frontiers in Neurology

doi 10.3389/fneur.2024.1372266

822 views
1 citation

Original Research

Published on 19 Apr 2024

Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis

in Multiple Sclerosis and Neuroimmunology

Óscar Fernández Fernández
Lucienne Costa-Frossard
Maria Luisa Martínez Ginés
Paloma Montero Escribano
José María Prieto González
Lluís Ramió-Torrentà
Yolanda Aladro
Ana Alonso Torres
Elena Álvarez Rodríguez
Andrés Labiano-Fontcuberta

Frontiers in Neurology

doi 10.3389/fneur.2024.1371644

1,410 views

Systematic Review

Published on 18 Apr 2024

Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 treatments: a systematic review and meta-analysis of 19,139 multiple sclerosis patients

in Multiple Sclerosis and Neuroimmunology

Anas Elgenidy
Nagham Nader Abdelhalim
Mohammed Al-mahdi Al-kurdi
Lobna A. Mohamed
Mohamed M. Ghoneim
Ahmed Wagdy Fathy
Hazem Khaled Hassaan
Ahmed Anan
Omar Alomari

Frontiers in Neurology

doi 10.3389/fneur.2024.1380654

3,119 views

Navigation group

Articles

Predictive value of synaptic plasticity for functional decline in patients with multiple sclerosis

Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series

Abnormal brain spontaneous neural activity in neuromyelitis optica spectrum disorder with neuropathic pain

Sex differences in Huntington's disease from a neuroinflammation perspective

Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation

A case report of AQP4-IgG-seropositive refractory neuromyelitis optica spectrum disorder patient with Sjögren’s syndrome and pancytopenia treated with inebilizumab

Effect of methylphenidate on oculomotor function in individuals with multiple sclerosis: a pilot randomized placebo-controlled trial

Editorial: Multiple sclerosis and related disorders: challenges and approaches to mechanisms, biomarkers, and therapeutic targets

Soluble biomarkers for Neuromyelitis Optica Spectrum Disorders: a mini review

Stem cell therapies: a new era in the treatment of multiple sclerosis

“A second birthday”? Experiences of persons with multiple sclerosis treated with autologous hematopoietic stem cell transplantation—a qualitative interview study

IL-6 receptor antibody treatment improves muscle weakness in experimental autoimmune myasthenia gravis mouse model

Patterns of multiple sclerosis presentation to the emergency department

Case report: Cerebrospinal fluid neutrophilic pleocytosis upon intrathecal triamcinolone injection

Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis

Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 treatments: a systematic review and meta-analysis of 19,139 multiple sclerosis patients